Neoadjuvant BRAF (dabrafenib) and MEK (trametinib) inhibition for high-risk resectable stage III and IV melanoma

Jennifer Ann Wargo; Rodabe Navroze Amaria; Merrick I. Ross; Robyn P. M. Saw; Jeffrey E. Gershenwald; Patrick Hwu; Sapna Pradyuman Patel; Isabella Claudia Glitza; Adi Diab; Richard Kefford; Richard A. Scolyer; Helen Rizos; John F. Thompson; Kerwin Shannon; Andrew Spillane; Matteo S. Carlino; Alex Guminski; Lauren Simpson; Michael A. Davies; Georgina V. Long

doi:10.1200/jco.2015.33.15_suppl.tps9091

Neoadjuvant BRAF (dabrafenib) and MEK (trametinib) inhibition for high-risk resectable stage III and IV melanoma

Jennifer Ann Wargo, Rodabe Navroze Amaria, Merrick I. Ross, Robyn P. M. Saw, Jeffrey E. Gershenwald, Patrick Hwu, Sapna Pradyuman Patel, Isabella Claudia Glitza, Adi Diab, Richard Kefford, Richard A. Scolyer, Helen Rizos, John F. Thompson, Kerwin Shannon, Andrew Spillane, Matteo S. Carlino, Alex Guminski, Lauren Simpson, Michael A. Davies, Georgina V. Long

Faculty of Medicine, Health and Human Sciences

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	TPS9091-TPS9091
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	33
Issue number	15 supplement
DOIs	https://doi.org/10.1200/jco.2015.33.15_suppl.tps9091
Publication status	Published - 20 May 2015
Event	Annual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States Duration: 31 May 2013 → 4 Jun 2013

Access to Document

10.1200/jco.2015.33.15_suppl.tps9091

Cite this

Wargo, J. A., Amaria, R. N., Ross, M. I., Saw, R. P. M., Gershenwald, J. E., Hwu, P., Patel, S. P., Glitza, I. C., Diab, A., Kefford, R., Scolyer, R. A., Rizos, H., Thompson, J. F., Shannon, K., Spillane, A., Carlino, M. S., Guminski, A., Simpson, L., Davies, M. A., & Long, G. V. (2015). Neoadjuvant BRAF (dabrafenib) and MEK (trametinib) inhibition for high-risk resectable stage III and IV melanoma. Journal of Clinical Oncology, 33(15 supplement), TPS9091-TPS9091. https://doi.org/10.1200/jco.2015.33.15_suppl.tps9091

@article{514401eb5aa14df7bfd134f51cd6bb9e,

title = "Neoadjuvant BRAF (dabrafenib) and MEK (trametinib) inhibition for high-risk resectable stage III and IV melanoma",

author = "Wargo, {Jennifer Ann} and Amaria, {Rodabe Navroze} and Ross, {Merrick I.} and Saw, {Robyn P. M.} and Gershenwald, {Jeffrey E.} and Patrick Hwu and Patel, {Sapna Pradyuman} and Glitza, {Isabella Claudia} and Adi Diab and Richard Kefford and Scolyer, {Richard A.} and Helen Rizos and Thompson, {John F.} and Kerwin Shannon and Andrew Spillane and Carlino, {Matteo S.} and Alex Guminski and Lauren Simpson and Davies, {Michael A.} and Long, {Georgina V.}",

year = "2015",

month = may,

day = "20",

doi = "10.1200/jco.2015.33.15_suppl.tps9091",

language = "English",

volume = "33",

pages = "TPS9091--TPS9091",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15 supplement",

note = "Annual Meeting of the American Society of Clinical Oncology (ASCO) ; Conference date: 31-05-2013 Through 04-06-2013",

}

Wargo, JA, Amaria, RN, Ross, MI, Saw, RPM, Gershenwald, JE, Hwu, P, Patel, SP, Glitza, IC, Diab, A, Kefford, R, Scolyer, RA, Rizos, H, Thompson, JF, Shannon, K, Spillane, A, Carlino, MS, Guminski, A, Simpson, L, Davies, MA & Long, GV 2015, 'Neoadjuvant BRAF (dabrafenib) and MEK (trametinib) inhibition for high-risk resectable stage III and IV melanoma', Journal of Clinical Oncology, vol. 33, no. 15 supplement, pp. TPS9091-TPS9091. https://doi.org/10.1200/jco.2015.33.15_suppl.tps9091

TY - JOUR

T1 - Neoadjuvant BRAF (dabrafenib) and MEK (trametinib) inhibition for high-risk resectable stage III and IV melanoma

AU - Wargo, Jennifer Ann

AU - Amaria, Rodabe Navroze

AU - Ross, Merrick I.

AU - Saw, Robyn P. M.

AU - Gershenwald, Jeffrey E.

AU - Hwu, Patrick

AU - Patel, Sapna Pradyuman

AU - Glitza, Isabella Claudia

AU - Diab, Adi

AU - Kefford, Richard

AU - Scolyer, Richard A.

AU - Rizos, Helen

AU - Thompson, John F.

AU - Shannon, Kerwin

AU - Spillane, Andrew

AU - Carlino, Matteo S.

AU - Guminski, Alex

AU - Simpson, Lauren

AU - Davies, Michael A.

AU - Long, Georgina V.

PY - 2015/5/20

Y1 - 2015/5/20

U2 - 10.1200/jco.2015.33.15_suppl.tps9091

DO - 10.1200/jco.2015.33.15_suppl.tps9091

M3 - Meeting abstract

SN - 0732-183X

VL - 33

SP - TPS9091-TPS9091

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15 supplement

T2 - Annual Meeting of the American Society of Clinical Oncology (ASCO)

Y2 - 31 May 2013 through 4 June 2013

ER -